Ellie Philpotts
Health Journalist at Freelance
Writer and Content Editor at RCN Bulletin
Writer & Content Editor @theRCN half the week, freelance journo the other half, @Doctors_net_uk and others (usually health)✍️ Story? I'd love to hear from you!
Articles
-
2 weeks ago |
pharmaceutical-journal.com | Medicines regulation |Ellie Philpotts
Medical and pharmacy regulators have published an enforcement notice warning that advertisements for named prescription-only medicines (POMs) for weight-management are prohibited. The notice was published jointly by the General Pharmaceutical Council (GPhC), Medicines and Healthcare products Regulatory Agency (MHRA) and Advertising Standards Authority (ASA) on 11 April 2025.
-
2 weeks ago |
pharmaceutical-journal.com | Ellie Philpotts
Research has revealed that patients were involved in the planning stages of just 18% of published clinical trials across several disease areas. The study, published in The BMJ on 10 April 2025, analysed the patient and public involvement — in how research is designed, conducted and disseminated — of 360 published articles reporting on randomised controlled trials and 299 respective protocols.
-
3 weeks ago |
pharmaceutical-journal.com | Ellie Philpotts
The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin (Adcetris; Takeda), in combination with other chemotherapy drugs, as the first NHS treatment for untreated late-stage classical Hodgkin lymphoma.
-
1 month ago |
inspirethemind.org | Ellie Philpotts
A hard pill to swallowUpon being confirmed to have cancer, you realise that so much of it is physical. Which is a hard pill to swallow, because you’d battled so much of it in private before reaching the point of diagnosis. Maybe you’d batted off your symptoms, blaming them on your young age or other easily explainable factors, be it a winter virus or the menopause. Maybe you’d battled to be taken seriously by doctors, who wouldn’t scan you until you’d come back time and time again.
-
1 month ago |
pharmaceutical-journal.com | Ellie Philpotts
The Scottish Drug Forum has warned pharmacists that multiple doses of naloxone may be needed to reverse drug overdoses, following the discovery of synthetic opioids in various street drugs in Scotland. In an ‘Overdose alert‘ issued on 13 March 2025, the Scottish Drug Forum warned that drug-related harm, including near-fatal overdoses, has increased throughout the country, with nitazenes being been found in several street drugs, including heroin.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 3K
- Tweets
- 37K
- DMs Open
- Yes
RT @MarkyOatcake: An interesting article to read about medications.
What should nursing staff know about particularly time-critical medications? My feature here ➡️https://t.co/UqKTTk3b3j
RT @YLvsCancer: Isobel was due to share her story just last week for Teenage and Young Adult Cancer Awareness Month. Sadly, we received the…
